The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 578.00
Bid: 576.00
Ask: 580.00
Change: -2.00 (-0.34%)
Spread: 4.00 (0.694%)
Open: 580.00
High: 582.00
Low: 573.00
Prev. Close: 582.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity and Total Voting Rights

26 Jan 2022 07:00

RNS Number : 6084Z
Marlowe PLC
26 January 2022
 

26 January 2022

 

 

Marlowe plc

("Marlowe", the "Company" or the "Group")

 

 

Issue of Equity and Total Voting Rights

 

 

Marlowe, the UK leader in business-critical services and software which assure regulatory compliance, announces that, following the achievement of profit targets in respect of the Group's 2020 acquisition of Elogbooks Facilities Management Limited and Elogbooks Facilities Services Limited (together with their subsidiaries, "Elogbooks"), final contingent consideration of £3.5m, including the issue of 93,016 new ordinary shares of 50 pence each in the Group (the "New Ordinary Shares") at an effective issue price of 1025 pence per ordinary share, will be payable by the Group in respect of the Acquisition.

 

Application has been made for 93,016 New Ordinary Shares to be admitted to trading on AIM ("Admission"). The New Ordinary Shares will rank pari passu with the Group's existing ordinary shares, and it is expected that Admission will occur at 8.00am on 27 January 2022.

 

Following Admission, the Company's issued ordinary share capital will comprise 95,833,853 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Marlowe following admission will be 95,833,853 ordinary shares.

 

The above figure of 95,833,853 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information:

 

Marlowe plc

 

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Adam Councell, Chief Financial Officer

IR@marloweplc.com

Julian Wais, Head of Investor Relations

Cenkos Securities plc

Nominated Adviser and Joint Broker

Tel: +44 (0)20 7397 8900

Nicholas Wells

Ben Jeynes

George Lawson

Joh. Berenberg, Gossler & Co. KG, London Branch

Joint Broker

Tel: +44 (0)20 3207 7800

Mark Whitmore

Ben Wright

Dan Gee-Summons

 

FTI Consulting

Tel: +44 (0)20 3727 1340

Nick Hasell

Alex Le May

 

 

About Marlowe plc

 

Marlowe is a UK leader in business-critical services and software which assure safety and regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBAMFTMTJTBBT
Date   Source Headline
4th Aug 20213:26 pmRNSForm 8.3 - MARLOWE PLC
4th Aug 20213:24 pmRNSForm 8.3 - MARLOWE PLC - Replacement for REF 4303H
4th Aug 202112:21 pmRNSForm 8.3 - RESTORE PLC
4th Aug 202111:59 amGNWForm 8.3 - [Marlowe plc - 03 08 2021] - (CGWL)
4th Aug 202111:35 amRNSForm 8.5 (EPT/RI)
4th Aug 20219:50 amRNSForm 8.5 (EPT/RI) - Marlowe Plc
4th Aug 20219:20 amRNSForm 8.5 (EPT/NON-RI)
3rd Aug 20212:42 pmGNWForm 8.3 - [Marlowe plc - 22 07 2021 - CORRECTION] - (CGWL)
3rd Aug 20211:15 pmRNSForm 8.3 - Restore Plc
3rd Aug 20211:06 pmRNSForm 8.5 (EPT/NON-RI)
3rd Aug 202112:01 pmRNSForm 8.3 - MARLOWE PLC
3rd Aug 202111:58 amRNSForm 8.3 - RESTORE PLC
3rd Aug 20219:25 amRNSForm 8.5 (EPT/RI)
3rd Aug 20217:00 amRNSForm 8.3 - Marlowe PLC
2nd Aug 20212:05 pmRNSForm 8.3 - MARLOWE PLC
2nd Aug 202111:55 amRNSForm 8.5 (EPT/NON-RI)
2nd Aug 202110:34 amRNSForm 8.5 (EPT/RI)
2nd Aug 20218:41 amRNSForm 8.5 (EPT/NON-RI)
30th Jul 20215:06 pmRNSForm 8.3 - Restore Plc
30th Jul 20214:58 pmRNSForm 8.3 - Marlowe Plc Amendment
30th Jul 20212:56 pmRNSForm 8.3 - Marlowe plc
30th Jul 20211:47 pmRNSForm 8.3 - Marlowe PLC
30th Jul 202112:34 pmRNSForm 8.3 - RESTORE PLC
30th Jul 202110:27 amRNSForm 8.5 (EPT/NON-RI)
30th Jul 20218:35 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 20212:50 pmRNSForm 8.3 - RESTORE PLC
29th Jul 202112:00 pmGNWForm 8.3 - [Marlowe plc - 28 07 2021] - (CGWL)
29th Jul 202110:07 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 20218:37 amRNSForm 8.5 (EPT/NON-RI)
29th Jul 20217:00 amRNSAcquisition of Barbour EHS from Informa plc
28th Jul 20215:55 pmRNSForm 8.5 (EPT/NON-RI)
28th Jul 20215:55 pmRNSForm 8.5 (EPT/NON-RI)
28th Jul 20211:50 pmRNSForm 8.3 - MARLOWE PLC
28th Jul 202112:57 pmRNSForm 8.3 - Marlowe PLC
28th Jul 202111:53 amGNWForm 8.3 - [Marlowe plc - 27 07 2021] - (CGWL)
28th Jul 202111:02 amRNSForm 8.3 - Marlowe plc
28th Jul 202110:54 amRNSForm 8.3 - Restore plc
28th Jul 202110:19 amRNSForm 8.5 (EPT/RI) - Marlowe Plc
27th Jul 20213:45 pmEQSMaitland Institutional Services Limited: Form 8.3 re Marlowe plc
27th Jul 20212:59 pmRNSForm 8.3 - MARLOWE PLC
27th Jul 20212:56 pmRNSForm 8.3 - RESTORE PLC
27th Jul 20211:51 pmPRNForm 8.3 DD - Marlowe plc
27th Jul 20211:05 pmRNSForm 8.3 - Marlowe PLC
27th Jul 202111:42 amGNWForm 8.3 - [Marlowe plc - 26 07 2021] - (CGWL)
27th Jul 202110:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jul 202110:35 amRNSForm 8.5 (EPT/RI)
27th Jul 20219:37 amRNSForm 8.5 (EPT/RI) - Marlowe Plc
27th Jul 20218:20 amRNSForm 8.5 (EPT/NON-RI)
26th Jul 20212:54 pmPRNForm 8.3 DD - Marlowe plc
26th Jul 20212:45 pmRNSForm 8.3 - RESTORE PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.